Written Question · S4W-03307 · Session 4
Further to the answer to question S4W-02856 by Nicola Sturgeon on 5 October 2011, what the timescale is for the review of the evidence on t…
The question
To ask the Scottish Executive, further to the answer to question S4W-02856 by Nicola Sturgeon on 5 October 2011, what the timescale is for the review of the evidence on transcatheter aortic valve implantation and what steps are being taken to ensure that it takes account of the updated guidance from the National Institute for Health and Clinical Excellence (NICE) and the health technology assessment commissioned by the National Institute for Health Research.
The answer
The National Planning Forum is charged with making recommendations on the provision of transcatheter aortic valve implantation (TAVI). As part of this process the Scottish Health Technologies Group has responsibility for monitoring and reviewing the evidence on the clinical and cost effectiveness of TAVI. Reports to be published by the National Institute for Health Research and National Institute for Health and Clinical Excellence will be considered as part of this process. The timing of the review of the evidence is dependent upon the date of publication of any new information, plus the time required for consideration and consultation within Scotland.
The National Institute for Health Research’s Health Technology Assessment (HTA) Programme previously indicated that work on the cost effectiveness of TAVI for aortic stenosis in patients who cannot undergo surgery would be made available in December 2011. However, an extension to the HTA review process is now expected to cause the forecast publication date to be delayed. The Interventional Procedures Programme (IPP) guidance on TAVI is expected to be published by National Institute for Health and Clinical Excellence (NICE) in November 2011.
The National Institute for Health Research’s Health Technology Assessment (HTA) Programme previously indicated that work on the cost effectiveness of TAVI for aortic stenosis in patients who cannot undergo surgery would be made available in December 2011. However, an extension to the HTA review process is now expected to cause the forecast publication date to be delayed. The Interventional Procedures Programme (IPP) guidance on TAVI is expected to be published by National Institute for Health and Clinical Excellence (NICE) in November 2011.
In the Official Report
No contribution in the Official Report cites S4W-03307 by reference.